ATAZANAVIR ALVOGEN 150mg capsules
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
letter A · page 88
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors
atazanavir Indicated for: HIV-1 infection
J05AE08 Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors